Hope is the most powerful drug in medicine.
It gives parents the courage to keep fighting, and patients the strength to endure.
And hope, when exploited, can also be the most dangerous weapon.
This week on The Doctor’s Lounge, we looked at the resignation of Vinay Prasad from the FDA, the controversy around Sarepta’s $3.2 million Duchenne gene therapy, and the larger question:
Who do we trust when science, money, and politics collide?
In this episode, we dig deep into the fragile intersection of innovation, regulation, and desperation.
Why accelerated approvals, meant to speed life-saving treatments, often leave families without the long-term data they deserve.
How regulators who push for caution quickly find themselves on the outside.
Why both the political right and left fail to understand the true mechanics of healthcare.
And most importantly, what happens when patients become pawns in a system designed to maximize profit, not outcomes.
Is this a debate about one gene therapy? Or is it about the system we are building for the next generation of patients, physicians, and families.
If healthcare is truly about “first, do no harm,” then we must ask: who decides what harm looks like, and who pays the price?
About The Doctor’s Lounge:
Where scalpels meet systems and physicians say what they really think.
Co-Hosts
Dutch Rojas – Founder, Bliksem Health and The Rojas Report
Anthony DiGiorgio, DO, MHA – Neurosurgeon, UCSF; health policy researcher
Anish Koka, MD – Cardiologist, Philadelphia; healthcare policy commentator
Dan Choi, MD, FAAOS – Orthopedic spine surgeon, Long Island; healthcare advocate and social media voice
Sanat Dixit, MD, FACS – Neurosurgeon, Huntsville, AL; Faculty, Vanderbilt University; healthcare entrepreneur
